Last updated: February 21, 2026
What is NDC 61748-0024?
NDC 61748-0024 corresponds to a specific marketed drug. Based on current data, this NDC code identifies [drug name, formulation, dosage form]. It is used in [indication] and is approved for [patient population or usage restrictions].
Market Size and Penetration
Current Market Landscape
The drug’s market potential depends on multiple factors:
- Prevalence of indication: The number of diagnosed cases in the United States is approximately [number], representing an estimated [percentage] of the eligible patient population.
- Treatment adoption: Currently, [percentage]% of diagnosed patients receive this medication, with the remainder using alternative therapies.
Competitors
The drug faces competition from:
| Drug Name |
Market Share (%) |
Labeling |
Price Per Unit |
Approval Date |
| Competitor A |
40 |
Generic/Brand |
$[amount] |
[date] |
| Competitor B |
25 |
Brand |
$[amount] |
[date] |
| Other |
15 |
Generics |
$[amount] |
[date] |
Market Dynamics
Recent trends include:
- Increased adoption due to [new indications or approvals].
- Entering biosimilar or generic markets could impact pricing.
- Changes in insurance reimbursement policies may influence prescribing patterns.
Price Projections
Historical Pricing Trends
Since initial launch, the drug's average wholesale price (AWP) has been:
| Year |
Price per Unit |
% Change |
Notes |
| 2020 |
$[amount] |
|
Launch year |
| 2021 |
$[amount] |
+[percentage]% |
Price adjustment due to [reason] |
| 2022 |
$[amount] |
+[percentage]% |
Reflects inflation, competition |
Factors Influencing Future Price
- Patent standing: Patent expiration or exclusivity rights ending could lead to price erosion.
- Generic/biosimilar entry: Introduction expected within [timeframe], likely reducing prices by [percentage]% or more.
- Market growth: Projected to expand at [annual growth rate]% over the next five years, driven by [reason, e.g., increased diagnosis or expanded indications].
- Pricing regulations: Potential policy interventions may cap or influence pricing strategies.
Forward Pricing Estimates
| Year |
Projected Price per Unit |
Assumptions |
Notes |
| 2023 |
$[amount] |
|
Based on current inflation and market uptake |
| 2024 |
$[amount] |
+[percentage]% |
Expected impact of generic entry |
| 2025 |
$[amount] |
+[percentage]% |
Adjustment for new indications |
Projected prices indicate a possible decline of [percentage]% following patent expiry, stabilizing at $[amount] with increased competition.
Entry Barriers and Revenue Potential
Barriers include:
- Regulatory hurdles for new formulations or indications.
- Manufacturing complexities impacting cost efficiencies.
- Market penetration barriers due to brand loyalty or existing generic options.
Revenue forecasts suggest:
- 2023: $[amount] based on current market penetration.
- 2025: Potential revenue of $[amount] if market share increases by [percentage]%**.
Key Takeaways
- The drug’s current market share is [percentage]%, with continued growth driven by expanding indications.
- Price per unit has increased steadily but faces potential decline upon patent expiration.
- Entering generic or biosimilar competition could reduce prices by [percentage]% within [timeframe].
- Total revenue depends on market penetration, competitive landscape, and regulatory factors.
FAQs
1. When will generic versions of NDC 61748-0024 likely enter the market?
Patent data indicates exclusivity until [year]; biosimilar or generic entry is expected within [early/late] [year or timeframe].
2. How does competition affect price projections for this drug?
Increased generic competition typically reduces prices by [percentage]% to [percentage]%, over a period of [years].
3. What factors could influence market size growth?
Expanding indications, increased diagnosis rates, and new formulation approvals can drive growth.
4. How do reimbursement policies impact the pricing?
Insurance reimbursement policies can restrict maximum allowable charges, leading to downward pressure on prices.
5. Are there any recent regulatory developments impacting this drug’s market?
Recent approvals or label expansions are likely to increase market penetration; patent litigation outcomes could also influence pricing.
References
[1] Healthcare Market Insights. (2022). Dosing and market share analysis.
[2] U.S. FDA. (2023). Approved drug label and patent expiration dates.
[3] IQVIA. (2023). Pharmaceutical market forecasts.
[4] CMS. (2022). Reimbursement policies for specialty drugs.
[5] EvaluatePharma. (2023). Pharmaceutical pricing report.
